Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nickel Catalyzed Asymmetric Alkylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel nickel catalyzed method offers mild conditions and high enantioselectivity for pharmaceutical intermediates manufacturing supply chain optimization and cost efficiency.
Patent CN113735669A details a cost-effective nickel-catalyzed method for constructing quaternary carbon chiral centers in alpha-acyllactams, offering significant supply chain advantages for pharmaceutical manufacturing.